Myocardial infarction: is evidence-based medicine the best?

Lancet. 2002 Apr 27;359(9316):1515-6. doi: 10.1016/s0140-6736(02)08419-2.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Cardiopulmonary Resuscitation
  • Evidence-Based Medicine / standards
  • Fibrinolytic Agents / therapeutic use
  • Humans
  • Myocardial Infarction / mortality
  • Myocardial Infarction / therapy*
  • Streptokinase / therapeutic use
  • Survival Rate
  • Tissue Plasminogen Activator / therapeutic use

Substances

  • Fibrinolytic Agents
  • Streptokinase
  • Tissue Plasminogen Activator